Instem
- Company typePrivate
- Founded1969
- HeadquartersConshohocken, United States
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
Instem firmographics
Firmographics- Name
- Instem
- Legal name
- Instem
- Website
- https://instem.com
- Company type
- Private
- Founded year
- 1969
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Ownership category
- akta.pro rank
Instem industry classification
Industry- Product category
- Life Sciences R&D Software
- NAICS
- Professional, Scientific, and Technical Services (54), Other Scientific and Technical Consulting Services (54169), Computer Systems Design Services (541512), Management, Scientific, and Technical Consulting Services (5416)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Engineering, Accounting, Research, Management (8700)
- akta.pro primary industry
- Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)
- akta.pro secondary industries
- Data Management, Biostatistics & Statistical Programming FSP (HLAGAOAB), Quality Assurance, GxP Compliance & Auditing FSP (HLAGAOAE), Quality Engineering & Risk Management (ICH Q9/Q10, validation, change control) (HLAGAKAL)
Keywords
Where Instem is headquartered
LocationHeadquarters
- HQ city
- Conshohocken
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Instem business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- SaaS Software Subscriptions: Instem generates revenue primarily through SaaS subscription licensing of its software platforms including Leadscope, Provantis, BioRails, Matrix Gemini LIMS, and Clinical Trial Analytics solutions. Annual and multi-year subscription contracts with enterprise customers.
- Professional Services: Instem Catalyst provides scientific and regulatory consulting services including strategy and advisory, implementation and modernization, validation and compliance, adoption and optimization, and resourcing/managed services.
- SEND Services: SEND Advantage Services including SEND Deliver, SEND Comply, SEND Advise, SEND Warehousing, and SEND Source for SEND data conversion and compliance services.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise SaaS subscription model |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels7 records
Instem product offering
Product offeringCore offering
Instem is a global SaaS provider for life sciences R&D, offering an integrated portfolio spanning in silico & data insights (Leadscope predictive toxicology), preclinical study management (Provantis, BioRails, Climb), regulatory submission (SEND Advantage Services, Submit), lab execution (Matrix Gemini LIMS), and clinical trial analytics (Accel, Aspire, Blur via d-wise). The company sells subscription-based software platforms and supporting professional services to pharmaceutical, biotech, CRO, CDMO, academic, and agrichemical organizations across 700+ clients globally.
Product overview
Instem is a global SaaS provider for life sciences R&D offering an integrated platform of solutions across In Silico & Data Insights, Study Management, Regulatory Submission, Lab Execution, and Clinical Trial Analytics. The portfolio includes core products such as Leadscope Model Applier, Predict, KnowledgeScan, Centrus, and Advance for predictive toxicology and data insights; Provantis, BioRails, Climb, Morphit, and Pristima for study management; SEND Advantage Services and Submit for regulatory submissions; Matrix Gemini LIMS for lab execution; and Accel, Aspire, Blur, and CTT Services for clinical trial analytics through d-wise (an Instem company). The company serves over 700 clients including pharmaceutical, biotech, CRO, CDMO, academic research, and agrichemical organizations. Founded in 1969, Instem has grown through acquisitions including RockStep Solutions, Xybion, and Autoscribe Informatics.
Differentiator
Problem solved
Functional benefit
Brands
- Leadscope: In silico predictive toxicology platform including Leadscope Model Applier, Predict, KnowledgeScan, Centrus, and Advance solutions
- Provantis
- Climb
- BioRails
- Matrix Gemini LIMS
- Predict
- KnowledgeScan
- Centrus
- Advance
- Accel
- Aspire
- Blur
- SEND Advantage
- Submit
Products and services
- Leadscope Model Applier Predictive QSAR modeling platform delivering accurate predictions for wide-ranging toxicological endpoints, driven by regulatory guidelines, enabling early risk assessments and reducing reliance on traditional animal testing.
- Predict Expert In Silico toxicology support service delivering a wide range of reports with proven regulatory acceptance for early-stage safety assessments.
- KnowledgeScan Technology-enabled Target Safety Assessment service that aggregates proprietary and public data, providing comprehensive insights into potential toxicological risks for faster data-driven decisions.
- Centrus Advanced Translational Safety Solution enabling data alignment, review, and visualizations from diverse sources for high-quality data management and seamless data sharing.
- Advance Expert-led S1B Weight of Evidence (WoE) assessment service evaluating carcinogenicity risks, supporting ICH S1B guidelines and accelerating development timelines.
- Climb Cloud-based preclinical in vivo data capture platform enabling capture from any therapeutic area to accelerate studies, with 75% reduction in setup time demonstrated.
- Provantis Industry-leading GLP-compliant preclinical study management software covering data capture, analysis, and reporting for non-clinical evaluation studies including study design, dosing, observations, and clinical pathology.
- Morphit Data visualization tool enabling real-time interpretation and analysis of complex datasets, allowing researchers to make informed adjustments to study parameters quickly.
- Pristima Xybion Legacy study management software for preclinical research data management and compliance.
- BioRails Discovery solution optimizing bioanalysis workflows, integrating seamlessly with various stages of research to support collaborative, real-time data access for in vitro ADME/DMPK and in vivo PK studies.
- Comet Assay IV Image analysis system providing consistent and reliable comet assay scoring for genetic toxicology studies.
- Logbook Electronic Laboratory Notebook (ELN) providing digital alternative to traditional lab records, capturing study notes and observations in secure, accessible format with data traceability and compliance.
- NOTOCORD-hem Software platform for acquisition, analysis, and custom reporting of physiological signals with focus on Cardiovascular, Respiratory and Nervous System Research.
- Cyto Study Manager Specialized genetic toxicology data capture and reporting platform with templates and tools for accurate documentation meeting compliance requirements in genetox studies.
- SEND Advantage Services Comprehensive managed services for SEND-compliant dataset generation including SEND Deliver, SEND Comply, SEND Advise, SEND Warehousing, and SEND Source programs.
- Submit SEND submission management suite providing centralized data control, automated updates, version control, and streamlined management for regulatory filings including SENDirect, DefineNow, GuidePro, SEND checker, SEND editor, and SENDView.
- Matrix Gemini LIMS Configurable Laboratory Information Management System covering data collection, storage, and reporting while meeting global compliance and quality standards with modules including LIMS Express, LIMS Stability, and Web Portal.
- Accel Cloud-based validated Statistical Computing Environment (SCE) providing scalable, compliant solution for data analysis and sharing with pre-configured biostats tools for streamlined collaboration.
- Aspire
Quantifiable outcome
- 75% reduction in setup time and 45% reduction in study design time
Companies that use Instem
Customer profileNamed customers5 records
Segments5 records
Ideal customer profiles5 records
Instem technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability9 records
Feature8 records
Instem partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core and minor.
- U.S. FDAcoreExtended 5-year Research Collaboration Agreement with U.S. FDA through February 2031, continuing a partnership established in 2011. The collaboration centers on the Leadscope platform to advance predictive toxicology models, expand curated safety databases, and enhance regulatory decision-support tools for drug safety assessments.
- U.S. FDAcoreCollaboration with FDA focuses on advancing predictive toxicology models, expanding curated safety databases, and enhancing regulatory decision-support tools. This extension reflects growing regulatory shift toward computational toxicology approaches and adoption of 3Rs principles to reduce animal testing.
- Autoscribe Informatics (Acquisition)coreAcquisition of Autoscribe Informatics contributed to Instem's expanded footprint in R&D solutions as part of growth strategy.
- ELRIGminorPresented research at ELRIG Drug Discovery 2025 showcasing drug discovery platforms BioRails and Climb, with case studies demonstrating efficiency gains.
- Xybion (Acquisition)coreInstem acquired all shares of Xybion from Banerjee Group LLC controlled by Dr. Pradip K. Banerjee, expanding Instem's preclinical study management capabilities.
- RockStep Solutions (Acquisition)coreAcquired RockStep Solutions and its Climb platform to strengthen in vivo study management capabilities within Instem's portfolio.
- Fraunhofer InstituteminorParticipated as part of a consortium led by Fraunhofer Institute in an EMA-funded research project investigating the mutagenicity of N-nitrosamines. Project aims to improve risk assessment and safety testing methods over a two-year period.
Scale indicators4 records
Recent moves9 records
Expansion highlights6 records
Instem competitors and assessment
Company assessmentBroad incumbents
- Veeva Systems: Public cloud-software leader for life sciences spanning clinical (Veeva Vault CTMS, EDC, eTMF), regulatory, quality, and commercial. Overlaps with Instem across clinical trial informatics, regulatory submissions, and quality management, but operates at much larger scale with a broader portfolio.
- Oracle Health Sciences: Oracle's Clinical One and safety/pharmacovigilance suites compete with Instem's clinical trial analytics (Accel, Aspire, Blur) and SEND/safety offerings. Broader enterprise footprint and deeper integration with Oracle's database and analytics stack differentiate it from Instem's specialized approach.
- Dassault Systèmes BIOVIA: Provides scientific informatics for discovery, preclinical, regulatory, and quality in life sciences. Directly comparable to Instem's in silico (Leadscope), study management (Provantis, BioRails), and lab execution (Matrix Gemini LIMS) suites, though positioned as a horizontal scientific platform rather than a regulatory-focused specialist.
- Revvity Signals: Signals Software (formerly PerkinElmer Informatics) provides TIBCO Spotfire-based analytics, LIMS, and ELN used by pharma discovery and translational labs. Competes with Instem's preclinical analytics, in silico, and LIMS offerings as part of a broader life sciences instrumentation and informatics portfolio.
- Thermo Fisher SampleManager / Watson LIMS: Thermo Fisher's informatics LIMS offerings (SampleManager LIMS, Watson LIMS for bioanalysis) compete with Matrix Gemini LIMS and BioRails in regulated bioanalytical and QC lab settings. Strong incumbent in large pharma labs where Instem Catalyst and d-wise analytics often co-bid.
Direct peers
- ArisGlobal: Life sciences R&D platform vendor with strong positions in pharmacovigilance/drug safety, regulatory affairs, and clinical trial master file management. Direct overlap with Instem's safety (Centrus), regulatory submission, and SEND/Submit capabilities, serving the same large-pharma and mid-pharma buyer base.
- Certara: Biosimulation, regulatory science, and drug development services/software vendor. Comparable to Instem in modeling-and-simulation-driven drug development (analogous to Leadscope QSAR) and in regulatory submission support, with deeper reach into model-based regulatory dossiers.
- LabWare: Independent LIMS and ELN vendor with deep penetration in regulated laboratories. Direct competitor to Instem's Matrix Gemini LIMS and Logbook ELN, particularly in pharma quality control and stability labs where both vendors actively bid.
- Dotmatics: Scientific R&D informatics platform for discovery and development, including ELN, LIMS, biology, and chemistry applications. Comparable to Instem's study management and lab execution portfolio, with comparable focus on data integration across life sciences R&D workflows.
Emerging players
- Schrödinger: Computational chemistry and predictive modeling platform increasingly applied to toxicology and drug safety. Overlaps with Instem's Leadscope QSAR/predictive toxicology franchise at the intersection of physics-based modeling and regulatory safety assessment.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Instem social profiles
Digital presenceInstem compliance and trust
Trust signalCompliance2 records
Instem financial estimates
Financial estimateRevenue estimate
Valuation estimate
Instem leadership team
Management profileNumber of profiles
Profiles7 records
Instem subsidiaries and ownership
Company hierarchySubsidiaries4 records
Instem funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Instem M&A and investment
M&A and investmentM&A14 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Instem
What does Instem do?
Instem is a global SaaS provider for life sciences R&D, offering an integrated portfolio spanning in silico & data insights (Leadscope predictive toxicology), preclinical study management (Provantis, BioRails, Climb), regulatory submission (SEND Advantage Services, Submit), lab execution (Matrix Gemini LIMS), and clinical trial analytics (Accel, Aspire, Blur via d-wise). The company sells subscription-based software platforms and supporting professional services to pharmaceutical, biotech, CRO, CDMO, academic, and agrichemical organizations across 700+ clients globally.
Is Instem a public or private company?
Instem is a private company. It is classified as public and is currently operating.
When was Instem founded?
Instem was founded in 1969. It employs 51 to 100 people.
Where is Instem based?
Instem is headquartered in Conshohocken, United States, in the North America region.
How does Instem make money?
Three revenue lines are on record. SaaS Software Subscriptions are the primary driver. The others are professional Services and SEND Services.
Who are Instem's main competitors?
Broad incumbents on record are Veeva Systems, Oracle Health Sciences, Dassault Systèmes BIOVIA, Revvity Signals and Thermo Fisher SampleManager / Watson LIMS. Direct peers are ArisGlobal, Certara, LabWare and Dotmatics. Schrödinger is listed as an emerging player.
Does Instem have an API?
No public API is recorded for Instem.
What industry is Instem in?
Instem's product category is Life Sciences R&D Software. Its primary akta.pro industry code is HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF), with a secondary code of HLAGAOAB, Data Management, Biostatistics & Statistical Programming FSP. Its NAICS code is 54 and its SIC code is 8731.